TO THE EDITOR
In this journal, Cotter et al. (2007) recently reported that they cannot detect Senescence-Associated b-Galactosidase (SA-b-Gal) activity at pH 6 in human nevi and conclude that nevi do not exhibit such activity. This is in contrast with recent reports by our laboratory and that of D Bennett (Michaloglou et al., 2005; Gray-Schopfer et al., 2006) . Here we explain why the claim put forth by Cotter et al. is based on a flawed interpretation of their experimental results. If anything, the paper by Cotter et al. confirms rather than refutes our previous report of increased SA-b-Gal activity in human nevi.
SA-b-Gal activity measured at pH 6 was originally identified by Dimri et al. (1995) as a senescence biomarker, because it increases in senescent cells in vitro as well as in vivo. Since this publication, literally hundreds of laboratories have used this marker for the identification of senescence in cells, in vitro and in vivo. The detection of SA-b-Gal in nevi by us and Bennett and co-workers has been paralleled by many similar findings in other in vivo lesions, including human dermal neurofibromas (Courtois-Cox et al., 2006) , human and murine prostatic adenomas (Chen et al., 2005) , murine lung adenomas, pancreatic intraductal neoplasias (Collado et al., 2005) , murine lymphomas (Braig et al., 2005) , and murine melanomas (Ha et al., 2007) .
We agree with the comment made by Cotter et al. that one should not use SA-b-Gal activity as the sole marker to detect senescence. Therefore, to detect senescence in nevi we have performed, in addition to SA-b-Gal staining, immunohistochemistry for the proliferation marker Ki-67 as well as the tumor suppressor p16 INK4A (Michaloglou et al., 2005) . In view of their comment, it is surprising that Cotter et al. neglected to do this.
Recently, Lee et al. (2006) have demonstrated that SA-b-Gal corresponds to lysosomal b-Galactosidase (b-Gal), which is consistent with the observation that senescent cells increase lysosome content (Kurz et al., 2000) .
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MelanA 200 μm Figure 1 . b-Gal activity in human nevi at pH range 4-7. (a) Paraffin (15 mm) sections of four samples of the same human nevus stained at pH range 4-7. Pieces of frozen tissue were fixed and stained for b-Gal activity at pH 4, 5, 6, or 7 in a staining solution containing 5 mM K 3 Fe(CN) 6 , 5 mM K 4 Fe(CN) 6 , 2 mM MgCl 2 , 150 mM NaCl, 1 mg/ml X-gal (in DMF), 40 mM citric acid/Na 2 HPO 4 , for 16 hours at 371C. The correct pH was confirmed before and after staining. Tissues were then embedded in paraffin (using isopropanol instead of xylene) and sectioned. Two consecutive sections are shown here, one of which has been counterstained with hematoxylin and eosin. Bar , 2006) . Photomicrographs shown here were generated without the help of any imaging software. The evaluation of specimens was not linked to clinical data at the individual level, and did not in any way influence diagnosis or treatment. According to institutional guidelines, no patient consent was deemed necessary, and none was sought.
activity between pH 4 and 4.5, but markedly lower activity at pH 6. The increase in lysosomal content of senescent cells favors detection of b-Gal activity at the suboptimal pH 6 (Lee et al., 2006, and references therein). However, even at pH 4, b-Gal staining differs between normal and senescent cells.
We have performed b-Gal stainings at pH 4-7. In agreement with the report by Lee et al. (2006) , we find that at pH 4 and 5, nevus cells show a clear positive staining, stronger in intensity than surrounding normal dermal or epidermal cells (fibroblasts and keratinocytes, respectively; Figure 1 ). At pH 6, although the total intensity of staining is reduced, there is a larger difference between the staining of nevus cells and the surrounding tissue, as we previously reported (Michaloglou et al., 2005) . No activity is detected at pH 7. Of note, and in contrast to the unfounded allegation by Cotter et al., we have meticulously controlled the pH and confirmed it before and after the staining procedure.
In contrast to their interpretation and claim, the data of Cotter et al. support rather than refute our observations and conclusions. In Figure 1e and f of their letter, they show nevus sections stained for b-Gal at pH 6 and 4, respectively. Although the limited resolution of that figure precludes detailed interpretation, specific staining at pH 4 is evident in the nevus compartment, with absence of staining in the adjacent non-neval cells. The only discrepancy with previous publications (Michaloglou et al., 2005; Gray-Schopfer et al., 2006) , therefore, lies at the pH at which b-Gal activity differences were detected, that is, pH 4 as opposed to pH 6. As it is the same enzyme that accounts for b-Gal activity measured at pH 4 and 6, one can conclude from the results by Cotter et al. only that, although their detection of the overall b-Gal activity has been less sensitive than the one used by us and many other laboratories, also the nevi they studied do in fact display increased activity of this enzyme. The results by Cotter et al. are 
We appreciate the interest in our letter (Cotter et al., 2007) , which emphasized two points: (1) that b-gal staining of nevi (in vivo) at pH 6 is unreliable, and (2) that it is premature to conclude that all nevi are senescent. We all agree that melanocyte senescence, resulting from oncogene activation or prolonged culture, is an established phenomenon in vitro that is associated with positive b-gal staining at pH 6. Indeed, as shown in our report, such staining of ''latepassage'' melanocytes was quite robust in our hands. Thus, as a positive control for our examination of nevi, we embedded late-passage melanocytes in OCT and prepared frozen sections in a www.jidonline.org 1583
